<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2023-385</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-7860</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЗАБОЛЕВАНИЯ КИШЕЧНИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BOWEL DISEASES</subject></subj-group></article-categories><title-group><article-title>Подходы к ведению пациентов хирургического профиля с антибиотик-ассоциированной диареей легкого течения</article-title><trans-title-group xml:lang="en"><trans-title>Approaches to the management of surgical patients with antibiotic-associated mild diarrhea</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3247-0600</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Егоров</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Egorov</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Егоров Денис Владимирович - кандидат медицинских наук, старший преподаватель 2-й кафедры  (терапии усовершенствования  врачей).</p><p>194044, Санкт-Петербург, ул. Академика Лебедева, д. 6</p></bio><bio xml:lang="en"><p>Denis V. Egorov - Cand. Sci. (Med.), Senior Lecturer of the 2nd  Department (Therapy of Advanced Training of Doctors), Military Medical Academy named  after S.M. Kirov.</p><p>6, Akademik Lebedev St., St Petersburg, 194044</p></bio><email xlink:type="simple">d.egorov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-6386-5739</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лазарева</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lazareva</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лазарева Юлия Анатольевна - преподаватель 2-й кафедры (терапии усовершенствования врачей).</p><p>194044, Санкт-Петербург, ул. Академика Лебедева, д. 6</p></bio><bio xml:lang="en"><p>Yulia A. Lazareva - Lecturer of the 2nd Department (Therapy of Advanced Training of Doctors), Military Medical Academy named  after S.M. Kirov.</p><p>6, Akademik Lebedev St., St Petersburg, 194044</p></bio><email xlink:type="simple">petrovaju@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5623-4226</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селивёрстов</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Seliverstov</surname><given-names>P. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Селивёрстов Павел Васильевич - кандидат медицинских наук, доцент 2-й кафедры (терапии усовершенствования врачей).</p><p>194044, Санкт-Петербург, ул. Академика Лебедева, д. 6</p></bio><bio xml:lang="en"><p>Pavel V. Seliverstov - Cand. Sci. (Med.), Associate Professor  of the  2nd Department (Therapy of Advanced Training of Doctors), Military Medical Academy named  after S.M. Kirov.</p><p>6, Akademik Lebedev St., St Petersburg, 194044</p></bio><email xlink:type="simple">seliverstov-pv@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Военно-медицинская академия имени С.М. Кирова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Military Medical Academy named after S.M. Kirov</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>04</day><month>11</month><year>2023</year></pub-date><volume>0</volume><issue>18</issue><fpage>128</fpage><lpage>133</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Егоров Д.В., Лазарева Ю.А., Селивёрстов П.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Егоров Д.В., Лазарева Ю.А., Селивёрстов П.В.</copyright-holder><copyright-holder xml:lang="en">Egorov D.V., Lazareva Y.A., Seliverstov P.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/7860">https://www.med-sovet.pro/jour/article/view/7860</self-uri><abstract><p>В работе освещены вопросы антибиотик-ассоциированной диареи (ААД) легкой степени тяжести при лечении пациентов хирургического профиля, ее эпидемиология, этиология, особенности клинической картины и подходы к терапии. К легкому течению ААД относится диарея  без признаков  интоксикации, лейкоцитоза  и лихорадки. Расстройство стула у пациентов, находящихся в условиях хирургического стационара  и получающих антибиотики, является актуальной медицинской проблемой, поскольку эта патология продлевает  время  госпитализации, увеличивает экономические  издержки, снижает качество жизни и даже может быть причиной летального исхода пациента. По данным разных авторов, ААД развивается у 40% лиц, получающих антибактериальную терапию. Подробно рассмотрен клинический пример ведения пациента с ААД и  травмой  опорно-двигательного   аппарата.  Отмена  антибиотиков  не  является  методом  решения  данной  проблемы, поскольку тяжесть повреждений   пациента требует дальнейшего оперативного   лечения и профилактики гнойно-септических осложнений. Ключевым пунктом в лечении ААД легкой степени тяжести будет являться назначение  пробиотических  препаратов,  оказывающих  действие  на  патогенетические   звенья  ААД.  Пробиотики  – это  микроорганизмы, известные с древнейших времен и целенаправленно применяемые с целью оздоровления  и долголетия. Одним из первых пробиотических  препаратов,  примененных  до эры открытия антибиотиков, можно считать мечниковскую простоквашу с  уникальными  лечебными  свойствами.  Назначение пробиотической терапии  с  первого  дня  приема  антибиотиков, до получения результатов лабораторного обследования, позволяет существенно снизить распространенность клинической манифестации как клостридиальной диареи, так и идиопатической ААД.</p></abstract><trans-abstract xml:lang="en"><p>The paper  highlights  the issues  of antibiotic-associated diarrhea  (AAD) of mild severity in the treatment of surgical patients, its epidemiology, etiology, features  of the clinical picture and approaches to therapy. The mild course of AAD includes diarrhea without  signs  of intoxication,  leukocytosis  and  fever. Stool  disorder  in patients receiving  antibiotics  who are  in a surgical hospital  is an urgent  medical  problem, since  this pathology  prolongs  the  time  of hospitalization, increases  economic  costs, reduces  the quality of life and can even be the cause of the patient’s death. According to various authors, AAD develops  in 40% of people  receiving antibacterial therapy. A clinical example  of the management of a patient  with AAD and injury of the musculoskeletal system is considered in detail.The abolition of antibiotics  is not a method  of solving this problem, since the severity of the patient’s injuries requires  further surgical treatment and prevention of purulent-septic complications. The key point in the  treatment of mild AAD will be the  appointment of probiotic  drugs, which have  an effect  on the  pathogenetic  links of AAD. Probiotics  are  microorganisms that  have  been  known  since  ancient  times  and  are  purposefully  used  for health improvement and longevity. One of the first probiotic drugs used before the era of the discovery of antibiotics  can be considered  Mechnikov curdled  milk with  unique  medicinal  properties.  Prescribing  probiotic  therapy  from the  first day of taking antibiotics, without  waiting for the results  of laboratory examination, will significantly reduce  the prevalence of clinical manifestations of both clostridial  diarrhea  and idiopathic AAD.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>колит</kwd><kwd>толстая кишка</kwd><kwd>диарея</kwd><kwd>пробиотики</kwd><kwd>синбиотики</kwd><kwd>лактазная недостаточность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>colitis</kwd><kwd>colon</kwd><kwd>diarrhea</kwd><kwd>probiotics</kwd><kwd>synbiotics</kwd><kwd>lactase deficiency</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Шаповалова ММ, Будневский АВ, Кравченко АЯ, Дробышева ЕС, Овсянников ЕС. Патогенез, современные аспекты профилактики и терапии антибиотик-ассоциированной диареи. Архивъ внутренней медицины. 2018;8(6):424–429. https://doi.org/10.20514/2226-6704-2018-8-6-424-429.</mixed-citation><mixed-citation xml:lang="en">Shapovalova MM, Budnevsky AV, Kravchenko AYa, Drobysheva ES, Ovsyannikov ES. Antibiotic-Associated Diarrhea: Pathogenesis, Actual Aspects of Prevention and Treatment. The Russian Archives of Internal Medicine. 2018;8(6):424–429. https://doi.org/10.20514/2226-6704-2018-8-6-424-429.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Косюра СД, Ильченко ЛЮ, Пожарицкая ЕИ, Мерзликина НН. Антибиотик-ассоциированная диарея. Лечебное дело. 2015;(1):131–134. Режим доступа: https://www.atmosphere-ph.ru/modules/Magazines/articles/delo/ld_1_2015_131.pdf.</mixed-citation><mixed-citation xml:lang="en">Kosyura SD, Ilchenko LYu, Pozharitskaya EI, Merzlikina NN. Antibiotic-associated diarrhea. Lechebnoe Delo. 2015;(1):131–134. (In Russ.) Available at: https://www.atmosphere-ph.ru/modules/Magazines/articles/delo/ld_1_2015_131.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Шляпников СА, Насер НР, Батыршин ИМ, Бородина МА, Склизков ДС, Остроумова ЮС, Рязанова ЕП. Антибиотик-ассоциированный колит – новая проблема в хирургии. Вестник Национального медико­хирургического центра им. Н.И. Пирогова. 2020;15(2):138–143. https://doi.org/10.25881/BPNMSC.2020.62.96.024.</mixed-citation><mixed-citation xml:lang="en">Shlyapnikov SA, Naser NR, Batyrshin IM, Borodina MA, Sklizkov DS, Ostroumova YuS, Ryazanova EP. The Antibiotic-associated colitis is a new problem in surgery. Bulletin of Pirogov National Medical &amp; Surgical Center. 2020;15(2):138–143. (In Russ.) https://doi.org/10.25881/BPNMSC.2020.62.96.024.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Al Sharaby A, Abugoukh TM, Ahmed W, Ahmed S, Elshaikh AO. Do Probiotics Prevent Clostridium difficile-Associated Diarrhea? Cureus. 2022;14(8):e27624. https://doi.org/10.7759/cureus.27624.</mixed-citation><mixed-citation xml:lang="en">Al Sharaby A, Abugoukh TM, Ahmed W, Ahmed S, Elshaikh AO. Do Probiotics Prevent Clostridium difficile-Associated Diarrhea? Cureus. 2022;14(8):e27624. https://doi.org/10.7759/cureus.27624.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Крюков ЕВ, Попова ТН, Паринов ОВ, Мешков ВВ. Антибиотикоассоциированные состояния в практике врача-гастроэнтеролога многопрофильного лечебного учреждения. Инфекционные болезни: новости, мнения, обучение. 2017;(6):79–84. https://doi.org/10.24411/2305-3496-2017-00008.</mixed-citation><mixed-citation xml:lang="en">Kryukov EV, Popova TN, Parinov OV, Meshkov VV. Antibiotic-associated states in the clinical practice of a gatroenterologist in a multifunctional medical centre. Infectious Diseases: News, Opinions, Training. 2017;(6):79–84. (In Russ.) https://doi.org/10.24411/2305-3496-2017-00008.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, Johnston BC. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12(12):CD006095. https://doi.org/10.1002/14651858.CD006095.pub4.</mixed-citation><mixed-citation xml:lang="en">Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, Johnston BC. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12(12):CD006095. https://doi.org/10.1002/14651858.CD006095.pub4.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Фоминых ЮА, Пахомова ИГ. Антибиотик-ассоциированные состояния в медицинской практике: актуальность проблемы, пути решения. РМЖ. 2012;(15):754–757. Режим доступа: https://www.rmj.ru/articles/gastroenterologiya/Antibiotikassociirovannye_sostoyaniya_v_medicinskoy_praktike_aktualynosty_problemy_puti_resheniya/.</mixed-citation><mixed-citation xml:lang="en">Fominykh YuA, Pakhomova IG. Antibiotic-associated conditions in medical practice: relevance of the problem, solutions. RMJ. 2012;(15):754–757. (In Russ.) Available at: https://www.rmj.ru/articles/gastroenterologiya/Antibiotikassociirovannye_sostoyaniya_v_medicinskoy_praktike_aktualynosty_problemy_puti_resheniya/.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Осипенко МФ, Бикбулатова ЕА. Осложнения антибиотикотерапии и их коррекция. Справочник поликлинического врача. 2012;(6):29–33. Режим доступа: https://omnidoctor.ru/upload/iblock/ce9/ce9f5b49c7f3e3d9d3294e1e810dba62.pdf.</mixed-citation><mixed-citation xml:lang="en">Osipenko MF, Bikbulatova EA. Complications of antibiotic therapy and their correction. Spravochnik Poliklinicheskogo Vracha. 2012;(6):29–33. (In Russ.) Available at: https://omnidoctor.ru/upload/iblock/ce9/ce9f5b49c7f3e3d9d3294e1e810dba62.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Захаренко СМ. Токсин-продуцирующие Klebsiella oxytoca как причина антибиотик-ассоциированного колита. Альманах клинической медицины. 2018;46(5):497–503. https://doi.org/10.18786/2072-0505-2018-46-5-497-503.</mixed-citation><mixed-citation xml:lang="en">Zakharenko SM. Toxin-producing Klebsiella oxytoca as a cause of antibiotic-associated colitis. Almanac of Clinical Medicine. 2018;46(5):497–503. (In Russ.) https://doi.org/10.18786/2072-0505-2018-46-5-497-503.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">La Fata G, Weber P, Mohajeri MH. Probiotics and the Gut Immune System: Indirect Regulation. Probiotics Antimicrob Proteins. 2018;10(1):11–21. https://doi.org/10.1007/s12602-017-9322-6.</mixed-citation><mixed-citation xml:lang="en">La Fata G, Weber P, Mohajeri MH. Probiotics and the Gut Immune System: Indirect Regulation. Probiotics Antimicrob Proteins. 2018;10(1):11–21. https://doi.org/10.1007/s12602-017-9322-6.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Успенский ЮП, Барышникова НВ. Антибиотик-ассоциированная диарея в условиях стационара: частота встречаемости и вопросы профилактики. Медицинский алфавит. 2021;(20):35–37. https://doi.org/10.33667/2078-5631-2021-20-35-37.</mixed-citation><mixed-citation xml:lang="en">Uspenskiy YuP, Baryshnikova NV. Antibiotic-associated diarrhea in hospital: frequency and prophylaxis. Medical Alphabet. 2021;(20):35–37. (In Russ.) https://doi.org/10.33667/2078-5631-2021-20-35-37.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Плотникова ЕЮ, Захарова ЮВ. Место пробиотиков в профилактике и лечении антибиотик-ассоциированной диареи. Терапевтический архив. 2015;87(5):127–131. https://doi.org/10.17116/terarkh2015875127-131.</mixed-citation><mixed-citation xml:lang="en">Plotnikova EYu, Zakharova IuV. Place of probiotics in the prevention and treatment of antibiotic-associated diarrhea. Terapevticheskii Arkhiv. 2015;87(5):127–131. (In Russ.) https://doi.org/10.17116/terarkh2015875127-131.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Евдокимова АГ, Жуколенко ЛВ, Иванова ТБ, Стрюк РИ. Коррекция микрофлоры кишечника синбиотиком Максилак. Экспериментальная и клиническая гастроэнтерология. 2019;(6):62–69. Режим доступа: https://www.nogr.org/jour/article/view/906.</mixed-citation><mixed-citation xml:lang="en">Evdokimova AG, Zhukolenko LV, Ivanova TB, Stryuk RI. Correction of intestinal microflora synbiotic Maxilac. Experimental and Clinical Gastroenterology. 2019;(6):62–69. (In Russ.) Available at: https://www.nogr.org/jour/article/view/906.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Int J Gen Med. 2016;9:27–37. https://doi.org/10.2147/IJGM.S98280.</mixed-citation><mixed-citation xml:lang="en">Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Int J Gen Med. 2016;9:27–37. https://doi.org/10.2147/IJGM.S98280.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Alberda C, Marcushamer S, Hewer T, Journault N, Kutsogiannis D. Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile. Nutrients. 2018;10(5):539. https://doi.org/10.3390/nu10050539.</mixed-citation><mixed-citation xml:lang="en">Alberda C, Marcushamer S, Hewer T, Journault N, Kutsogiannis D. Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile. Nutrients. 2018;10(5):539. https://doi.org/10.3390/nu10050539.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu LB, Zhang YC, Huang HH, Lin J. Prospects for clinical applications of butyrate-producing bacteria. World J Clin Pediatr. 2021;10(5):84–92. https://doi.org/10.5409/wjcp.v10.i5.84.</mixed-citation><mixed-citation xml:lang="en">Zhu LB, Zhang YC, Huang HH, Lin J. Prospects for clinical applications of butyrate-producing bacteria. World J Clin Pediatr. 2021;10(5):84–92. https://doi.org/10.5409/wjcp.v10.i5.84.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez H, Miller JE. Do prophylactic probiotics prevent the incidence of Clostridium difficile colitis infection in hospitalized patients? J Okla State Med Assoc. 2019;112(1):18–19. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677267/.</mixed-citation><mixed-citation xml:lang="en">Rodriguez H, Miller JE. Do prophylactic probiotics prevent the incidence of Clostridium difficile colitis infection in hospitalized patients? J Okla State Med Assoc. 2019;112(1):18–19. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677267/.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zavisic G, Petricevic S, Radulovic Z, Begovic J, Golic N, Topisirovic L, Strahinic I. Probiotic features of two oral Lactobacillus isolates. Braz J Microbiol. 2012;43(1):418–428. https://doi.org/10.1590/S1517-838220120001000050.</mixed-citation><mixed-citation xml:lang="en">Zavisic G, Petricevic S, Radulovic Z, Begovic J, Golic N, Topisirovic L, Strahinic I. Probiotic features of two oral Lactobacillus isolates. Braz J Microbiol. 2012;43(1):418–428. https://doi.org/10.1590/S1517-838220120001000050.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000;130(Suppl. 2):396S–402S. https://doi.org/10.1093/jn/130.2.396S.</mixed-citation><mixed-citation xml:lang="en">Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000;130(Suppl. 2):396S–402S. https://doi.org/10.1093/jn/130.2.396S.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L, Zeng X, Guo D, Zou Y, Gan H, Huang X. Early use of probiotics might prevent antibiotic-associated diarrhea in elderly (&gt;65 years): a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):562. https://doi.org/10.1186/s12877-022-03257-3.</mixed-citation><mixed-citation xml:lang="en">Zhang L, Zeng X, Guo D, Zou Y, Gan H, Huang X. Early use of probiotics might prevent antibiotic-associated diarrhea in elderly (&gt;65 years): a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):562. https://doi.org/10.1186/s12877-022-03257-3.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kopacz K, Phadtare S. Probiotics for the Prevention of Antibiotic-Associated Diarrhea. Healthcare (Basel). 2022;10(8):1450. https://doi.org/10.3390/healthcare10081450.</mixed-citation><mixed-citation xml:lang="en">Kopacz K, Phadtare S. Probiotics for the Prevention of Antibiotic-Associated Diarrhea. Healthcare (Basel). 2022;10(8):1450. https://doi.org/10.3390/healthcare10081450.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015;60(Suppl. 2):S108–121. https://doi.org/10.1093/cid/civ177.</mixed-citation><mixed-citation xml:lang="en">Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015;60(Suppl. 2):S108–121. https://doi.org/10.1093/cid/civ177.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(Suppl. 2):444S–450S. https://doi.org/10.1093/ajcn/73.2.444s.</mixed-citation><mixed-citation xml:lang="en">Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(Suppl. 2):444S–450S. https://doi.org/10.1093/ajcn/73.2.444s.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Yun B, Oh S, Griffiths MW. Lactobacillus acidophilus modulates the virulence of Clostridium difficile. J Dairy Sci. 2014;97(8):4745–4758. https://doi.org/10.3168/jds.2014-7921.</mixed-citation><mixed-citation xml:lang="en">Yun B, Oh S, Griffiths MW. Lactobacillus acidophilus modulates the virulence of Clostridium difficile. J Dairy Sci. 2014;97(8):4745–4758. https://doi.org/10.3168/jds.2014-7921.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W, Zhu B, Xu J, Liu Y, Qiu E, Li Z, Li Z, He Y, Zhou H, Bai Y, Zhi F. Bacteroides fragilis Protects Against Antibiotic-Associated Diarrhea in Rats by Modulating Intestinal Defenses. Front Immunol. 2018;9:1040. https://doi.org/10.3389/fimmu.2018.01040.</mixed-citation><mixed-citation xml:lang="en">Zhang W, Zhu B, Xu J, Liu Y, Qiu E, Li Z, Li Z, He Y, Zhou H, Bai Y, Zhi F. Bacteroides fragilis Protects Against Antibiotic-Associated Diarrhea in Rats by Modulating Intestinal Defenses. Front Immunol. 2018;9:1040. https://doi.org/10.3389/fimmu.2018.01040.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
